3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
19
Lung Neoplasms
11
Squamous Cell Carcinoma of Head and Neck
8
Prostatic Neoplasms
6
Prostatic Neoplasms, Castration-Resistant
4
Stomach Neoplasms
3
Neoplasms
3
Neoplasm Metastasis
3
Endometrial Neoplasms
3
Carcinoma, Transitional Cell
3
Breast Neoplasms
3
Urinary Bladder Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Melanoma
2
Lymphoid Interstitial Pneumonia
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Carcinoma
2
Vaccinia
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Non-small Cell Lung Cancer Metastatic
1
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Interventions
Cyclophosphamide
7
Mycophenolic Acid
5
Whole-Body Irradiation
4
Busulfan
4
fludarabine phosphate
3
fludarabine
3
Tacrolimus
3
Rituximab
3
Prednisone
3
Methotrexate
3
Inotuzumab Ozogamicin
3
Etoposide
3
Cytarabine
3
Cyclosporine
3
venetoclax
2
ruxolitinib
2
pegfilgrastim
2
asciminib
2
Vincristine
2
Peripheral Blood Stem Cell Transplantation
2
Mercaptopurine
2
Filgrastim
2
Dexamethasone
2
Calcium Dobesilate
2
tocilizumab
1
ricolinostat
1
rasburicase
1
ponatinib
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor, human
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia
×
Docetaxel
×
30 days
×
Clear all
No trials found.